| Line Item | 2024-02-29 | Y/Y |
|---|---|---|
| Revenue | $35.8M | +5.1% |
| Cost of Revenue | $31.9M | +0.6% |
| Gross Profit | $3.9M | +66.6% |
| R&D Expense | $700K | -12.3% |
| SG&A Expense | $6.6M | +16.0% |
| Operating Income | -$3.8M | +42.7% |
| Interest Expense | $121K | -78.5% |
| Pre-tax Income | -$3.8M | +49.4% |
| Net Income | -$3.8M |
| Line Item | 2024-02-29 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.5M | -83.6% |
| Accounts Receivable | $9.2M | +585.7% |
| Current Assets | $18.7M | +8.5% |
| Total Assets | $18.8M | +7.2% |
| Current Liabilities | $6.8M | +231.6% |
| Total Liabilities | $6.8M | +47.6% |
| Stockholders' Equity | $12.1M | -6.6% |
| Line Item | 2024-02-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.2M | +4.8% |
| Capital Expenditures | $376 | -99.5% |
| Investing Cash Flow | -$376 | +99.5% |
| Financing Cash Flow | -$295K | -101.7% |
| Free Cash Flow | -$8.2M | +5.6% |
| +50.2% |
| EPS (Basic) | -$0.07 | +58.8% |
| EPS (Diluted) | -$0.07 | +58.8% |